HMGB1-mediated autophagy decreases sensitivity to oxymatrine in SW982 human synovial sarcoma cells

Yongsong Cai1, Peng Xu2, Le Yang2

  • 1Department of Orthopaedics of the First Affiliated Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.

Scientific Reports
|November 30, 2016
PubMed

Insights

Oxymatrine (OMT) shows antitumor effects in human synovial sarcoma cells by increasing autophagy. This autophagy, mediated by high mobility group box protein 1 (HMGB1), protects cells; inhibiting it enhances OMT

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Oxymatrine (OMT), an alkaloid from Sophora flavescens, has known antitumor properties.
  • The effects of OMT on human synovial sarcoma and its underlying mechanisms remain uninvestigated.

Purpose of the Study:

  • To investigate the antitumor activity of OMT on SW982 human synovial sarcoma cells.
  • To determine the role of high mobility group box protein 1 (HMGB1)-mediated autophagy in OMT's therapeutic effects.

Main Methods:

  • Cell culture of SW982 human synovial sarcoma cells.
  • Treatment with Oxymatrine (OMT), autophagy inhibitors (3-MA, ATG7 siRNA), and HMGB1 inhibitors (HMGB1-siRNA).
  • Analysis of cell apoptosis, autophagy markers, and protein expression (HMGB1, p-Akt, p-mTOR).

Main Results:

  • OMT demonstrated antitumor activity and induced autophagy in SW982 cells.
  • Inhibition of autophagy increased OMT-induced apoptosis, indicating a protective role for autophagy.
  • OMT increased HMGB1 expression; HMGB1 inhibition reduced OMT-induced autophagy and increased apoptosis, suggesting HMGB1's role in autophagy regulation via the Akt/mTOR pathway.

Conclusions:

  • OMT exhibits antitumor effects on human synovial sarcoma cells, partly through HMGB1-mediated autophagy.
  • OMT-induced autophagy is a protective mechanism; its inhibition enhances OMT's cytotoxicity.
  • Combining OMT with autophagy or HMGB1 inhibitors may improve treatment efficacy for human synovial sarcoma.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K